Trovan

Trovan, an antibiotic which was approved by the FDA in December, 1997, has been found to cause serious liver injuries in some patients. It has been on the market since February, 1998. The FDA issued an advisory to physicians that the drug (trovafloxacin/alatrofloxacin), in both the oral and intravenous formulations, should be used only in the case of serious life-threatening infections.

If you or a loved one is in need of legal assistance, call Lea, Rhine, Rosbrugh & Chleborowicz, P.L.L.C. at (910) 772-9960 or toll free at (866) 772-9960 or submit an online questionnaire. If we agree to handle your case, we will work on a contingency fee basis, which means we get paid for our services only if there is a monetary recovery of funds. In many cases, a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. Please call right away to ensure that you do not waive your right to possible compensation.

Copyright © 2006 Lea, Rhine, Rosbrugh & Chleborowicz – North Carolina personal injury attorneys, motor vehicle accident lawyers and product liability attorneys,
serving Wilmington, New Hanover county and cities throughout North Carolina. All rights reserved. MegaSites by MegaHunter - VLPC.

North Carolina Pharmaceutical Litigation Lawyers Disclaimer: The North Carolina pharmaceutical litigation, mass tort drug case, drug injury, personal injury and/or other legal information offered herein by Lea, Rhine, Rosbrugh & Chleborowicz, Wilmington Pharmaceutical Litigation Lawyers, is not formal legal advice nor the formation of an attorney client relationship. Any results set forth herein are based only upon the facts of that particular case and offer no promise or guarantee on the outcome of any case. This site is not intended to solicit clients outside the State of North Carolina.

Web Site Marketing by: SLS Consulting - Lawyer, Attorney, Law Firm and Legal Web Sites